Novacta Biosystems Limited announces collaboration with AstraZeneca
18 May 2004

>Download PDF

18 May 2004 – Novacta Biosystems Limited today announced that it is collaborating in a study with AstraZeneca to produce drug metabolites using its METABOLITE FACTORY technology.

Commenting on the agreement, Dr Mike Dawson, Novacta's Director of Research, said 'We are delighted to have the opportunity to use our technology in conjunction with AstraZeneca. We look forward to a productive relationship that capitalises on the strengths of Navacta's biotransformation technology and expertise in this area'.

Novacta Biosystems Limited is a privately owned company based in Hatfield UK. Novacta uses its platform of biotransformation and biosynthetic engineering technologies in research and development services for the pharmaceutical, chemical, food and cosmetic industries, and in research and development of its own novel drug compounds.

Further enquiries:
Max Bautin
GEIF Ventures Ltd
max.bautin@geifventures.co.uk

Dr John Sime
Business Development Director
Novacta Biosystems Limited
UH Innovation Centre
University of Hertfordshire
College Lane
Hatfield
Herts
AL10 9AB
Tel. 01707 281038
john.sime@novactabio.com
www.novactabio.com

Notes to Editors:

Novacta Biosystems Limited www.novactabio.com
Novacta Biosystems Ltd is a privately owned company and earlier this year was the subject of an investment by GEIF ventures and others. Novacta has recently relocated to larger facilities in Hatfield in the Innovation Centre at the University of Hertfordshire

Great Eastern Investment Forum www.geif.co.uk
GEIF is a leading UK business angels network strategically based in Cambridge. It is the fundamental link between early stage companies and business angels seeking quality investment opportunities. GEIF introductions, through regular company presentations and breakfast meetings, provide a secure and confidential business environment. GEIF website brings members all the latest investment opportunities and other relevant news. Since GEIF was launched in 1995, its members have helped over 150 early stage companies to raise in excess of £20 million of investment and to strengthen their teams with invaluable management skills. Membership of GEIF includes private investors, corporate investors, venture capitalists and corporate advisers.

Back to Index